Joyce A. Cramer is President of the Epilepsy Therapy Project, a non-profit organization advancing new therapies for people living with epilepsy , and Associate Research Scientist at Yale University School of Medicine, New Haven, CT. Her academic career includes several decades of work in epilepsy and clinical trials to evaluate treatment outcomes. She developed methods for the evaluation of antiepileptic drug efficacy and adverse effects, study design and management, and enhancement of medication compliance, as well as instruments to assess quality of life, treatment satisfaction, and other patient-reported outcomes.

Her publications include 5 books, more than 180 peer-reviewed manuscripts, 35 book chapters, and numerous abstracts, covering topics in medicine, neurology, psychiatry, research design, medication compliance & persistence, quality of life, and other patient-reported outcomes. The books are titled: Quantitative Assessment in Epilepsy Care, Quality of Life and Pharmacoeconomics: An Introduction, Alcohol and Seizures, Patient Compliance in Medical Practice and Clinical Trials, Patient Recruitment in Clinical Trials.

Joyce has been a member of the Epilepsy Therapy Project Governing Board since its inception. Her professional activities have included positions as Treasurer of the American Epilepsy Society (AES), AES Board of Directors, Chair of the Board of Trustees of the AES-William G. Lennox Fund. She also has served on the Board of Directors of the Society for Clinical Trials and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

She currently serves on the Editorial Boards of Epilepsy & Behavior, Acta Neurologica Scandinavica, and Management Advisory Board for Value in Health. She has served on the Editorial Board for Epilepsia, chaired the ILAE Commission on Outcome Measurement, and the ISPOR section on Medication Compliance. She was Associate Editor of epilepsy.com and professionals.epilepsy.com, website resources for patients, families, and healthcare providers.

She has received the Ambassador Award from the International League Against Epilepsy (ILAE) and the AES Service Award, as well as the International Research Promotion Council/World Scientist Forum Award: Eminent Scientist of the Year, and was twice awarded the ISPOR Distinguished Service Award.